GlassScriptPhysician profile
Manabu Fujita
NPI 1174888937
$2,666.83
in general payments reported to CMS, 2019-2025
13 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,079 · 2020: $258 · 2021: $53.14 · 2023: $258 · 2024: $679 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,276.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,137.18 | 2019-2024 | |
| Urgo Medical North America, LLC | $397.27 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Boston Scientific Corporation | $198.75 | 2019-2020 | |
| Acell, INC. | $158.55 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $151.16 | 2025 | |
| Medical Device Business Services, INC. | $125.00 | 2024 | |
| Portola Pharmaceuticals, LLC | $124.91 | 2020 | |
| Ethicon US, LLC | $116.41 | 2025 | Surgicel Nu-Knit, Evarrest, Surgiflo Hemostatic Matrix |
| Baxter Healthcare | $100.00 | 2024 | Floseal |
| Medtronic, INC. | $72.32 | 2025 | Signia |
| Myriad Genetic Laboratories, INC. | $36.25 | 2021 | |
| Hologic Sales and Service, LLC | $32.14 | 2023 | Coolseal Generator |
| Abbvie INC. | $16.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manabu Fujita listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.